Susquehanna International Group
DFTX

Susquehanna International Group’s Definium Therapeutics DFTX Stock Holding History

Susquehanna International Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9M Buy
840,000
+256,400
+44% +$4.35M ﹤0.01% 2501
2025
Q4 		$7.81M Sell
583,600
-213,800
-27% -$2.65M ﹤0.01% 3376
2025
Q3 		$9.4M Buy
797,400
+459,200
+136% +$4.28M ﹤0.01% 3119
2025
Q2 		$2.19M Buy
338,200
+69,500
+26% +$457K ﹤0.01% 5604
2025
Q1 		$1.57M Buy
268,700
+194,600
+263% +$1.39M ﹤0.01% 6100
2024
Q4 		$516K Sell
74,100
-137,300
-65% -$945K ﹤0.01% 8589
2024
Q3 		$1.2M Sell
211,400
-368,300
-64% -$2.56M ﹤0.01% 6370
2024
Q2 		$4.18M Sell
579,700
-366,300
-39% -$3.2M ﹤0.01% 3736
2024
Q1 		$8.89M Sell
946,000
-165,700
-15% -$945K ﹤0.01% 2770
2023
Q4 		$4.07M Buy
1,111,700
+45,900
+4% +$138K ﹤0.01% 4068
2023
Q3 		$3.34M Buy
1,065,800
+104,000
+11% +$427K ﹤0.01% 4199
2023
Q2 		$3.43M Sell
961,800
-42,000
-4% -$145K ﹤0.01% 4146
2023
Q1 		$3.18M Sell
1,003,800
-862,200
-46% -$2.87M ﹤0.01% 4206
2022
Q4 		$4.11M Sell
1,866,000
-214,300
-10% -$595K ﹤0.01% 3537
2022
Q3 		$7.28M Buy
2,080,300
+1,997,220
+2,404% +$19.2M ﹤0.01% 2591
2022
Q2 		$798K Sell
83,080
-26,433
-24% -$334K ﹤0.01% 7076
2022
Q1 		$1.82M Buy
109,513
+45,346
+71% +$787K ﹤0.01% 5685
2021
Q4 		$1.33M Buy
64,167
+1,007
+2% +$32.1K ﹤0.01% 6513
2021
Q3 		$2.21M Buy
63,160
+21,480
+52% +$929K ﹤0.01% 5613
2021
Q2 		$2.16M Buy
+41,680
New +$2.19M ﹤0.01% 5745

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's DFTX Position: Q1 2026 in Review

Susquehanna International Group reduced its Definium Therapeutics (DFTX) stake by 83% in Q1 2026, selling an estimated $6.71M and leaving 81,456 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6810.

Susquehanna International Group first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. The position peaked at $6.39M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Susquehanna International Group held 81,456 shares of Definium Therapeutics worth $1.54M as of Q1 2026.
  • Susquehanna International Group sold 395,656 Definium Therapeutics shares in Q1 2026, an estimated $6.71M.
  • Definium Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6810 holding.
  • Susquehanna International Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Definium Therapeutics position peaked at $6.39M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.